埃沃特克任命阿希克·H.汗博士为其新任执行副总裁和首席商务官. Evotec appoints Dr. Ashiq H. Khan as its new Executive Vice President and Chief Commercial Officer.

埃沃特克公司任命阿希克·H. Evotec SE has appointed Dr. Ashiq H. Khan as its Executive Vice President and Chief Commercial Officer. 卡恩在生物技术和人工智能驱动平台方面拥有超过15年的经验, 在高价值协议中获得了70多亿美元. Khan brings over 15 years of experience in biotech and AI-driven platforms, having secured over $7 billion in high-value agreements. 他将领导一个全球一体化的商业组织, 与Evotec的科学实力保持一致, 推动药物开发早期创新. He will lead a globally integrated commercial organization aligned with Evotec's scientific strengths to drive innovation in early-stage drug development.